Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA OVEREXPRESSION COOPERATES WITH INK4A/ARF LOSS TO PROMOTE GLIOMAGENESIS—ROLES OF SHP-2 AND PI3K PATHWAYS

Liu, Kun-Wei (2011) PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA OVEREXPRESSION COOPERATES WITH INK4A/ARF LOSS TO PROMOTE GLIOMAGENESIS—ROLES OF SHP-2 AND PI3K PATHWAYS. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

[img]
Preview
PDF
Primary Text

Download (9MB) | Preview

Abstract

BACKGROUND: Human gliomas account for the most common and malignant tumors in the central nervous system (CNS). Despite optimal treatments, survival of patients with high-grade glioblastoma multiforme (GBM) remains poor. Recent coordinated genomic analyses of a large cohort of clinical GBM specimens identified frequent co-alterations of genes in three core pathways—the P53, retinoblastoma (RB), and receptor tyrosine kinase (RTK) pathways that are crucial in gliomagenesis. Further multi-institutional efforts have sub-classified GBMs into four clinical relevant subtypes based on their signature genetic lesions. Among them, PDGFRA overexpression is concomitant with a loss of CDKN2A locus (encoding P16INK4A and P14ARF) in a large number of tumors within one subtype of GBMs. To better understand and design therapeutic strategies against gliomas driven by abnormal platelet-derived growth factor (PDGF) signaling, functional studies using human or mouse models are needed. MAJOR FINDINGS: In order to establish a model that allows us to assess contributions of different signaling pathways to PDGFRα-induced glioma formation, we generated Ink4a/Arf-deficient primary mouse astrocytes (referred to as mAst hereafter) and human glioma cells that overexpress PDGFRα and/or PDGF-A. We found that activation of PDGFRα confers tumorigenicity to Ink4a/Arf-deficient mAst and human glioma cells in the brain. Restoration of p16INK4a but not p19ARF by retroviral transduction suppresses PDGFRα-promoted glioma formation. Mechanistically, abrogation of signaling modules in PDGFRα that lost capacity to bind to SH-2-containing phosphotyrosine phosphatase SHP-2 or Phosphoinositol 3'-Kinase (PI3K) significantly diminished PDGFRα-promoted tumorigenesis. Furthermore, inhibition of SHP-2 by shRNAs or pharmacological inhibitors disrupted the interaction of PI3K with PDGFRα, suppressed downstream AKT/mTOR activation, and impaired tumorigenesis of Ink4a/Arf-null cells, whereas expression of an activated PI3K mutant rescued the effect of SHP-2 inhibition on tumorigenicity. In clinical glioblastoma specimens, PDGFRα and PDGF-A are co-expressed and such co-expression is linked with activation of SHP-2/AKT/mTOR-signaling. Our data thus suggest that in glioblastomas with Ink4a/Arf deficiency, overexpressed PDGFRα promotes tumorigenesis through the PI3K/AKT/mTOR-mediated pathway regulated by SHP-2 activity.SIGNIFICANCE: We expect these findings will improve our understanding of the formation of the gliomas with PDGFRA and INK4A/ARF aberrations. There were studies that predicted SHP-2/PTPN11 as one of the linker genes in clinical GBMs that interact with multiple commonly altered genes. Our results functionally validate this hypothesis and identify SHP-2 as a converge point of several signaling pathways such as PDGFR, EGFR, PI3K, and mTOR that are frequently deregulated in GBMs. It thus represents a promising target for treatments against this fatal disease.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: University of Pittsburgh ETD
Status: Unpublished
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Liu, Kun-Weiluvkiss0716@gmail.com
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairMonga, Satdarshan P Smongass@upmc.eduSMONGA
Committee MemberBowser, Robertbowserrp@upmc.edu
Committee MemberCheng, Shi-Yuanchengs@upmc.edu
Committee MemberLi, Luyuanlil@upmc.edu
Committee MemberSobol, Robert Wrws9@pitt.eduRWS9
Date: 2 June 2011
Date Type: Completion
Defense Date: 27 April 2011
Approval Date: 2 June 2011
Submission Date: 6 May 2011
Access Restriction: No restriction; Release the ETD for access worldwide immediately.
Institution: University of Pittsburgh
Schools and Programs: School of Medicine > Cellular and Molecular Pathology
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: GLIOMA; INK4A/ARF; PDGF; PI3K; SHP-2
Other ID: http://etd.library.pitt.edu/ETD/available/etd-05062011-164222/, etd-05062011-164222
Date Deposited: 10 Nov 2011 19:43
Last Modified: 19 Dec 2016 14:36
URI: http://d-scholarship.pitt.edu/id/eprint/7808

Metrics

Monthly Views for the past 3 years

Plum Analytics


Actions (login required)

View Item View Item